GenSight Biologics S.A. (EPA:SIGHT)
France flag France · Delayed Price · Currency is EUR
0.0835
+0.0019 (2.33%)
Aug 3, 2026, 2:34 PM CET

GenSight Biologics Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2.422.462.1310.6144.29
Cash & Short-Term Investments
2.422.462.1310.6144.29
Cash Growth
-1.99%15.46%-79.89%-76.04%16.72%
Accounts Receivable
00000.75
Other Current Assets
2.572.884.3912.348.32
Total Current Assets
4.985.346.5322.9553.36
Net Property, Plant & Equipment
0.430.932.032.272.55
Other Intangible Assets
00.060.080.090.11
Other Long-Term Assets
2.854.420.50.630.62
Total Assets
8.2610.769.1325.9456.65
Accounts Payable
5.926.365.637.8111.56
Current Portion of Long-Term Debt
3.6913.31171.544.68
Current Portion of Leases
0.350.590.780.890.74
Other Current Liabilities
2.712.361.884.45.27
Total Current Liabilities
12.6722.6225.2914.6422.24
Long-Term Debt
13.784.75.1114.4610.58
Long-Term Leases
00.511.050.971.51
Other Long-Term Liabilities
6.749.848.3911.156.32
Total Long-Term Liabilities
20.5315.0614.5426.5818.42
Total Liabilities
33.237.6839.8341.2240.66
Common Stock
5.523.121.631.161.16
Additional Paid-in Capital
217.41206.61190.94181.21181.18
Retained Earnings
-247.87-236.65-223.27-197.65-166.34
Shareholders' Equity
-24.94-26.92-30.7-15.2815.99
Total Liabilities & Equity
8.2610.769.1325.9456.65
Total Debt
17.8219.1123.9317.8617.51
Net Cash (Debt)
-15.41-16.65-21.8-7.2526.78
Net Cash Growth
----42.36%
Net Cash Per Share
-0.10-0.17-0.45-0.160.59
Book Value
-24.94-26.92-30.7-15.2815.99
Book Value Per Share
-0.17-0.28-0.64-0.330.35
Tangible Book Value
-24.94-26.98-30.78-15.3715.88
Tangible Book Value Per Share
-0.17-0.28-0.64-0.330.35